ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 223 filers reported holding ZAI LAB LTD in Q3 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,101,437 | -53.9% | 168,714 | -47.4% | 0.01% | -53.3% |
| Q2 2023 | $8,902,550 | -12.7% | 321,044 | +4.7% | 0.03% | -14.3% |
| Q1 2023 | $10,200,576 | +12.1% | 306,692 | +3.5% | 0.04% | +6.1% |
| Q4 2022 | $9,096,594 | -48.0% | 296,306 | -42.1% | 0.03% | -2.9% |
| Q3 2022 | $17,489,701 | +29.3% | 511,386 | +31.1% | 0.03% | +36.0% |
| Q2 2022 | $13,525,635 | -36.5% | 390,002 | +15.0% | 0.02% | -53.7% |
| Q4 2021 | $21,305,000 | -16.8% | 338,991 | +39.6% | 0.05% | -25.0% |
| Q3 2021 | $25,593,000 | -69.4% | 242,840 | -48.7% | 0.07% | -40.0% |
| Q2 2021 | $83,748,000 | +325.7% | 473,172 | +220.9% | 0.12% | +100.0% |
| Q1 2021 | $19,675,000 | +77.8% | 147,459 | +10.8% | 0.06% | +50.0% |
| Q3 2020 | $11,067,000 | -54.8% | 133,054 | -55.3% | 0.04% | -16.7% |
| Q2 2020 | $24,472,000 | +53.1% | 297,984 | -4.0% | 0.05% | +20.0% |
| Q1 2020 | $15,980,000 | -17.9% | 310,424 | -33.6% | 0.04% | 0.0% |
| Q4 2019 | $19,458,000 | +70.7% | 467,856 | +32.7% | 0.04% | +73.9% |
| Q3 2019 | $11,402,000 | +12.6% | 352,474 | +21.4% | 0.02% | +15.0% |
| Q2 2019 | $10,124,000 | – | 290,338 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 304,820 | $10,154 | 23.52% |
| Tree Line Advisors (Hong Kong) Ltd. | 460,000 | $15,299,600 | 11.92% |
| Genesis Investment Management, LLP | 1,569,764 | $52,210 | 5.67% |
| Privium Fund Management B.V. | 240,683 | $8,005,117 | 2.69% |
| Segantii Capital Management Ltd | 2,278,275 | $75,775,427 | 2.66% |
| Paradigm Biocapital Advisors LP | 780,558 | $25,961,359 | 2.46% |
| HSG Holding Ltd | 694,634 | $23,103,527 | 2.43% |
| E Fund Management (Hong Kong) Co., Ltd. | 82,587 | $2,747 | 1.53% |
| INDUS CAPITAL PARTNERS, LLC | 25,256 | $840,015 | 1.29% |
| Vivo Capital, LLC | 416,640 | $13,857,446 | 0.96% |